Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

Signal transduction pathways

DR. MOHAMMAD AAMIR HALEEM
1ST YEAR RESIDENT DEPARTMENT OF PATHOLOGY, PIMS, KARIMANAGAR, TELENAGANA

  • Als Erste(r) kommentieren

Signal transduction pathways

  1. 1. DR AAMIR (presenter) 1ST YEAR RESIDENT DEPT OF PATHOLOGY 19-01-2016. DR MAHESH KUMAR (moderator)
  2. 2. 1. INTRODUCTION. 2. SIGNAL TRANSDUCTION. 3. RECEPTORS. 4. EXTRACELLULAR RECEPTORS. 4a. G-PROTEIN COUPLED RECEPTORS. 4b. RECEPTORS WITH KINASE ACTIVITY. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 2
  3. 3. 4b1. RECEPTOR TYROSINE KINASE. 4b2. NON RECEPTOR TYROSINE KINASE. JAK-STAT PATHWAYS. 4c. INTEGRINS. 4d. TOLL GATE RECEPTORS. 4e. LIGAND-GATED ION CHANNELS. 5. INTRACELLULAR RECEPTORS. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 3
  4. 4. 1.INTRODUCTION  In human body, numerous processes are required for coordinating individual cells to support the body as a whole.  At the cellular level, Sensing of environments and cell communication for coordination relies on signal transduction; modeling signal transduction systems as self-organizing allows one to explain how equilibria are maintained.  Many disease processes, such as diabetes and heart disease arise from defects or dysregulations in these pathways, highlighting the importance of these processes in human biology and medicine 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 4
  5. 5.  Cell communication occurs through chemical signals and cellular receptors by either the  1) direct contact of molecules on two cells surfaces or the  2) release of a "chemical signal" recognized by another cell (near or far).  Hormones are carried by the circulatory systems to many sites.  Growth factors are released to act on nearby tissues.  Ligands are signals that bind cell surface receptors (as observed with insulin (a ligand) and the insulin receptor) or that can pass into the cell and bind an internal receptor (such as the steroid hormones). 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 5
  6. 6. 2. SIGNAL TRANSDUCTION  Any process occurring within cells that convert one kind of signal/stimulus into another type.  It also known as cell signaling in which the transmission of molecular signals from a cell's exterior to its interior.  Signals received by cells must be transmitted effectively into the cell to ensure an appropriate response. This step is initiated by cell-surface receptors which triggers a biochemical chain of events inside the cell, creating a response. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 6
  7. 7.  It is also defined as the ability of a cell to change behavior in response to a receptor-ligand interaction.(signal)  The ligand is the primary messenger.  As the result of binding the receptor, other molecules or second messengers are produced within the target cell.  Second messengers relay the signal from one location to another (such as from plasma membrane to nucleus) leading to cascade of events/changes within a cell 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 7
  8. 8. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 8
  9. 9.  Messenger molecules may be amino acids, peptides, proteins, fatty acids, lipids, nucleosides or nucleotides.  Hydrophilic messengers bind to cell membrane receptors.  Hydrophobic messengers bind to intracellular receptors which regulate expression of specific genes. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 9
  10. 10.  A ligand binds its receptor through a number of specific weak non-covalent bonds by fitting into a specific binding site or "pocket".  In situations where even low concentrations of a ligand will result in binding of most of the cognate receptors, the receptor affinity is considered to be high.  Low receptor affinity occurs when a high concentration of the ligand is required for most receptors to be occupied.  The dissociation constant (Kd) is the concentration of ligand required to occupy one half of the total available receptors. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 10
  11. 11.  With prolonged exposure to a ligand (and occupation of the receptor) cells often become desensitized.  Desensitization of the cell to a ligand depends upon receptor down-regulation.  Desensitization may lead to tolerance, a phenomenon that results in the loss of medicinal effectiveness of some medicines that are over prescribed. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 11
  12. 12. 3.RECEPTORS  Receptors can be roughly divided into two major classes: intracellular receptors and extracellular receptors. 4.EXTRACELLULAR RECEPTORS  Extracellular receptors are integral transmembrane proteins and make up most receptors.  They span the plasma membrane of the cell, with one part of the receptor on the outside of the cell and the other on the inside.  Signal transduction occurs as a result of a ligand binding to the outside region of the receptor (the ligand does not pass through the membrane). 1/19/2016 SIGNAL TRANSDUCTION MECHANISMS 12
  13. 13. Various Extracellular Receptors  G protein-coupled receptors.  Receptors with Kinase activity.  Integrin receptors.  Toll gate receptors.  Ligand-gated ion channel receptors. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 13
  14. 14. 4a. G PROTEIN–COUPLED RECEPTORS (GPCRs)  Also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, and G protein–linked receptors (GPLR).  These constitute a large protein family of receptors that sense molecules outside the cell and activate inside signal transduction pathways and, ultimately, cellular responses.  Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 14
  15. 15.  The ligands that bind and activate these receptors include  light-sensitive compounds,  odors, pheromones, hormones,  and neurotransmitters, and vary in size from small molecules to peptides to large proteins.  G protein–coupled receptors are involved in many diseases, and are also the target of approximately 40% of all modern medicinal drugs. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 15
  16. 16. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 16
  17. 17.  G proteins, also known as guanine nucleotide-binding proteins, are a family of proteins that act as molecular switches inside cells, and are involved in transmitting signals from a variety of stimuli outside a cell to its interior.  When they are bound to GTP, they are 'on', and, when they are bound to GDP, they are 'off'.  G proteins belong to the larger group of enzymes called GTPases 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 17
  18. 18.  There are two classes of G proteins.  The first function as monomeric small GTPases,  The second form and function as heterotrimeric G protein complexes.  Heterotrimeric class of complexes is made up of alpha (α), beta (β) and gamma (γ) subunits. The beta and gamma subunits can form a stable dimeric complex referred to as the beta-gamma complex while alpha subunit dissociates on activation. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 18
  19. 19. MECHANISM  It is known that in the inactive state, the GPCR is bound to a heterotrimeric G protein complex.  Binding of an agonist to the GPCR results in a conformation change in the receptor that is transmitted to the bound Gαsubunit of the heterotrimeric G protein.  The activated Gα subunit exchanges GTP in place of GDP which in turn triggers the dissociation of Gα subunit from the Gβγ dimer and from the receptor. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 19
  20. 20.  CONTD..  The dissociated Gα and Gβγ subunits interact with other intracellular proteins to continue the signal transduction cascade.  While the freed GPCR is able to rebind to another heterotrimeric G protein to form a new complex that is ready to initiate another round of signal transduction. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 20
  21. 21. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 21
  22. 22.  There are two principal signal transduction pathways involving the G protein–coupled receptors:  A. the cAMP signal pathway and  B. the phosphatidylinositol signal pathway.  A. cAMP-DEPENDENT PATHWAY,  It is also known as the adenylyl cyclase pathway.  In a cAMP-dependent pathway, the activated Gs alpha subunit binds to and activates an enzyme called adenylyl cyclase, which, in turn, catalyzes the conversion of ATP into cyclic adenosine monophosphate (cAMP). 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 22
  23. 23. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 23  Increases in concentration of the second messenger cAMP may lead to the activation of:  cyclic nucleotide-gated ion channels.  exchange proteins activated by cAMP (EPAC) such as RAPGEF3  popeye domain containing proteins (Popdc)  an enzyme called protein kinase A (PKA).
  24. 24.  The PKA enzyme is also known as cAMP-dependent enzyme because it gets activated only if cAMP is present. Once PKA is activated, it phosphorylates a number of other proteins including:  enzymes that convert glycogen into glucose  enzymes that promote muscle contraction in the heart leading to an increase in heart rate  transcription factors, which regulate gene expression 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 24
  25. 25. Molecules that activate cAMP pathway include:  cholera toxin - increase cAMP levels  caffeine and theophylline inhibit cAMP phosphodiesterase, which degrades cAMP - thus enabling higher levels of cAMP than would otherwise be had.  pertussis toxin, which increase cAMP levels by inhibiting Gi to its GDP (inactive) form. This leads to an increase in adenylyl cyclase activity, thereby increasing cAMP levels, which can lead to an increase in insulin and therefore hypoglycemia 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 25
  26. 26.  DEACTIVATION  The Gs alpha subunit slowly catalyzes the hydrolysis of GTP to GDP, which in turn deactivates the Gs protein, shutting off the cAMP pathway.  The pathway may also be deactivated downstream by directly inhibiting adenylyl cyclase or dephosphorylating the proteins phosphorylated by PKA.  Molecules that inhibit the cAMP pathway include:  cAMP phosphodiesterase dephosphorylates cAMP into AMP, reducing the cAMP levels  Gi protein, which is a G protein that inhibits adenylyl cyclase, reducing cAMP levels. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 26
  27. 27.  B. PHOSPHATIDYLINOSITOL SIGNAL PATHWAY;  In the phosphatidylinositol signal pathway, the extracellular signal molecule binds with the G-protein receptor (Gq) on the cell surface and activates phospholipase C, which is located on the plasma membrane. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 27 phospholipase C
  28. 28. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 28  IP3 binds with the IP3 receptor in the membrane of the smooth endoplasmic reticulum and mitochondria to open Ca2+ channels.  DAG helps activate protein kinase C (PKC), which phosphorylates many other proteins, changing their catalytic activities, leading to cellular responses.
  29. 29. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 29
  30. 30.  The effects of Ca2+ are also remarkable:  It cooperates with DAG in activating PKC and can activate the CaM kinase pathway, in which calcium-modulated protein calmodulin (CaM) binds Ca2+, undergoes a change in conformation, and activates CaM kinase.  The kinase then phosphorylates target enzymes, regulating their activities. The two signal pathways are connected together by Ca2+-CaM, which is also a regulatory subunit of adenylyl cyclase and phosphodiesterase in the cAMP signal pathway. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 30
  31. 31. WHEN G PROTEIN SIGNALING IS DISRUPTED  G protein-related diseases are characterized by either deficient or excessive G protein signal transmission, which arises through abnormal signal initiation, defective termination, or reduced levels of G proteins  Deficient G protein signaling can arise through either reduced levels of G proteins, or through decrease signal initiation. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 31
  32. 32.  Diseases involving a decrease in the production of G proteins include;  Night Blindness, where mutations in G(t) protein a subunits affect the response of rod cells to light.  Pseudo hypoparathyroidism, where the genetic loss of G(s) protein a subunits results in non-responsiveness to parathyroid hormone.  Other abnormalities involve decreased signal initiation through the inability of G proteins to switch to active states, e.g. the symptoms of Whooping Cough (Pertussis) like hypoglycemia 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 32
  33. 33.  Excessive G protein signaling can arise through either increased signal initiation, or defective signal termination.  Increased signal initiation occurs in Testotoxicosis, where a mutation in the receptor for luteinizing hormone can over- stimulate G(s) proteins, resulting in the excessive production of testosterone.  Diseases arising from defective signal termination result from the persistent elevated activity of downstream effectors, such as in Cholera, the symptoms of which results from the action of a bacterial toxin that lead to stimulation of adenylyl cyclase and the subsequent secretion of salt and water leading to fatal diarrhea. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 33
  34. 34.  Two other diseases involve defective termination through mutations in G(s) protein a subunits, including;  Adenomas, in which G proteins lose their ability to hydrolyze GTP through mutation, resulting in the excessive secretion of growth hormone and the increased proliferation of somatotrophs.  McCune-Albright Syndrome, where scattered regions of skin hyper-pigmentation arise from the hyper-functioning of one or more endocrine glands. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 34
  35. 35. 4b. RECEPTORS WITH KINASE ACTIVITY;  A kinase is a type of enzyme that transfers phosphate groups from high-energy donor molecules, such as ATP (see below) to specific target molecules (substrates); the process is termed phosphorylation.  For every phosphorylation event, there is a phosphatase, an enzyme that can remove phosphate residue and thus modulate signaling  Kinase enzymes that specifically phosphorylate tyrosine amino acids are termed tyrosine kinases. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 35
  36. 36. 1. RECEPTOR TYROSINE KINASE(RTKs)  It is a cell surface receptor that also has a tyrosine kinase activity.  The signal binding domain of the receptor tyrosine kinase is on the cell surface, while the tyrosine kinase enzymatic activity resides in the cytoplasmic part of the protein. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 36
  37. 37.  A transmembrane alpha helix connects these two regions of the receptor.  As is the case with GPCRs, proteins that bind GTP play a major role in signal transduction from the activated RTK into the cell.  In this case, the G proteins are members of the Ras, Rho, and Raf families, referred to collectively as small G proteins 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 37
  38. 38.  The most important groups of signals that bind to receptor tyrosine kinases are:  peptide growth factors like nerve growth factor (NGF) and epidermal growth factor (EGF)  peptide hormones, like insulin.  Binding of signal molecules to the extracellular domains of receptor tyrosine kinase molecules causes two receptor molecules to dimerize.  This brings the cytoplasmic tails of the receptors close to each other and causes the tyrosine kinase activity of these tails to be turned on. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 38
  39. 39.  The activated tails then phosphorylate each other on several tyrosine residues. This is called autophosphorylation.  The phosphorylation of tyrosines on the receptor tails triggers the assembly of an intracellular signaling complex on the tails.  The newly phosphorylated tyrosines serve as binding sites for a variety of signaling proteins that then pass the message on to yet other proteins.  An important protein that is subsequently activated by the signaling complexes on the receptor tyrosine kinases is called RAS. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 39
  40. 40. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 40
  41. 41. 1/19/201 6 SIGNAL TRANSDUCTION MECHANISMS 41
  42. 42.  The RAS protein has the following important features:  1. It is associated with the cytosolic face of the plasma membrane 2. It is a monomeric GTP-binding protein (in fact, it is a lot like the alpha subunit of trimeric G-proteins). 3. Just like the alpha subunit of a G-protein, Ras is active when GTP is bound to it and inactive when GDP is bound to it. Like the a subunit, Ras can hydrolyze the GTP to GDP  This excited signal-emitting state is short-lived, however, because the intrinsic (GTPase) activity of RAS hydrolyzes GTP to GDP, returning the protein to its quiescent GDP-bound state 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 42
  43. 43.  Activated RAS triggers a phosphorylation cascade of protein kinases, which relay and distribute the signal. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 43
  44. 44.  These protein kinases are members of a group called the MAP kinases (Mitogen Activated Protein Kinases).  The final kinase in this cascade phosphorylates various target proteins, including transcriptional activators (e.g.myc) that regulate gene expression.  RAS is the most commonly mutated proto-oncogene in human tumors. Indeed, approximately 30% of all human tumors contain mutated versions of the RAS gene, and the frequency is even higher in some specific cancers (e.g., colon and pancreatic adenocarcinomas). 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 44
  45. 45.  2. NON RECPETOR TYROSINE KINASE (nRTKs)  Non-receptor tyrosine kinases are a subgroup of protein family tyrosine kinases, enzymes that can transfer the phosphate group from ATP to a tyrosine residue of a protein (phosphorylation).  Unlike the receptor tyrosine kinases (RTKs), the second subgroup of tyrosine kinases, the non-receptor tyrosine kinases are cytoplasmic enzymes.  nRTKs regulate cell's growth, proliferation, differentiation, adhesion, migration and apoptosis and they are critical components in the regulation of the immune system. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 45
  46. 46.  The main function of nRTKs is their involvement in signal transduction in activated T- and B-cells in the immune system.  CD4 and CD8 receptors on T lymphocytes require for their signaling the Src family member Lck.  Src, cellular homolog of transforming protein of Rous Sarcoma Virus, is prototype for an important family of such nRTKs 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 46
  47. 47.  Src contains unique functional regions such as Src-homology 2 (SH2) and Src- homology 3 (SH3).  SH2 domains typically bind to receptors phosphorylated by another kinase, allowing the aggregation of multiple enzymes.  SH3 domains mediate other protein-protein interactions. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 47
  48. 48. JAK-STAT Signaling pathway  The JAK-STAT signaling pathway transmits information from chemical signals outside the cell, through the cell membrane, and into gene promoters on the DNA in the cell nucleus, which causes DNA transcription and activity in the cell.  The JAK-STAT system is a major signaling alternative to the second messenger system and is an example of nRTK.  The JAK-STAT system consists of three main components:  1. a receptor  2. Janus kinase (JAK) and  3. Signal Transducer and Activator of Transcription (STAT). 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 48
  49. 49.  Many JAK-STAT pathways are expressed in white blood cells, and are therefore involved in regulation of the immune system.  MECHANISM.  The binding of the ligand to the receptor triggers activation of JAKs.  With increased kinase activity, they phosphorylate tyrosine residues on the receptor and create sites for interaction with proteins that contain phosphotyrosine-binding SH2 domains. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 49
  50. 50.  STATs possessing SH2 domains capable of binding these phosphotyrosine residues are recruited to the receptors, and are themselves tyrosine-phosphorylated by JAKs  These phosphotyrosines then act as binding sites for SH2 domains of other STATs, mediating their dimerization. Different STATs form hetero- or homodimers.  Activated STAT dimers accumulate in the cell nucleus and activate transcription of their target genes 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 50
  51. 51. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 51
  52. 52.  JAK-STAT pathway mutations are associated with many hematological malignancies caused by gaining constitutive functions e.g.  MYELOPROLIFERATIVE NEOPLASMS; Ph negative MPNs  MDS  MULTIPLE MYELOMA. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 52
  53. 53. 4c. INTEGRINS  Integrins are produced by a wide variety of cells; they play a role in:  1. Cell attachment to other cells and the extracellular matrix and  2. In the transduction of signals from extracellular matrix components such as fibronectin and collagen.  Ligand binding to the extracellular domain of integrins changes the protein's conformation, clustering it at the cell membrane to initiate signal transduction. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 53
  54. 54.  Integrins lack kinase activity; hence, integrin-mediated signal transduction is achieved through a variety of intracellular protein kinases and adaptor molecules, the main coordinator being integrin-linked kinase.  Integrin signaling exist in two places mainly;  Integrin-signaling in circulating blood cells and non-circulating cells such as epithelial cells. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 54
  55. 55.  Important differences exist between two is that integrins of circulating cells are normally inactive.  For example, cell membrane integrins on circulating leukocytes are maintained in an inactive state to avoid epithelial cell attachment; they are activated only in response to stimuli such as those received at the site of an inflammatory response.  In a similar manner, integrins at the cell membrane of circulating platelets are normally kept inactive to avoid thrombosis.  Epithelial cells (which are non-circulating) normally have active integrins at their cell membrane, helping maintain their stable adhesion to underlying stromal cells that provide signals to maintain normal functioning 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 55
  56. 56. 4c. TOLL GATE RECEPTORS  Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system.  TLRs are a type of pattern recognition receptor (PRR) and recognize molecules that are broadly shared by pathogens but distinguishable from host molecules, collectively referred to as pathogen-associated molecular patterns (PAMPs). 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 56
  57. 57. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 57
  58. 58. 4e. LIGAND-GATED ION CHANNEL  Ligand-gated ion channels (LGICs) are a group of transmembrane ion channel proteins which open to allow ions such as Na+, K+,Ca2+, or Cl− to pass through the membrane in response to the binding of a chemical messenger (i.e. a ligand), such as a neurotransmitter.  A ligand-gated ion channel, upon binding with a ligand, changes conformation to open a channel in the cell membrane through which ions relaying signals can pass. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 58
  59. 59.  An example of this mechanism is found in the receiving cell of a neural synapse.  The influx of ions that occurs in response to the opening of these channels induces action potentials, such as those that travel along nerves, by depolarizing the membrane of post- synaptic cells, resulting in the opening of voltage-gated ion channels.  Ligand-gated ion channels are likely to be the major site at which anaesthetic agents and ethanol have their effects, in particular, the GABA and NMDA receptors are affected by anaesthetic agents. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 59
  60. 60. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 60
  61. 61. 5. INTRACELLULAR RECEPTORS  Intracellular receptors are receptors located inside the cell rather than on its cell membrane.  Classic hormones that use intracellular receptors include thyroid and steroid hormones.  Examples are:  Class of nuclear receptors located in the cell nucleus and cytoplasm  IP3 receptor located on the endoplasmic reticulum. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 61
  62. 62.  The ligands that bind to them are usually:  Intracellular second messengers like inositol trisphosphate (IP3)  Extracellular lipophilic hormones like steroid hormones.  Activated nuclear receptors attach to the DNA at receptor- specific hormone-responsive element (HRE) sequences, located in the promoter region of the genes activated by the hormone- receptor complex.  Due to their enabling gene transcription, they are alternatively called inductors of gene expression. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 62
  63. 63.  All hormones that act by regulation of gene expression have two consequences in their mechanism of action;  1. their effects are produced after a characteristically long period of time  2. their effects persist for another long period of time, even after their concentration has been reduced to zero, due to a relatively slow turnover of most enzymes and proteins that would either deactivate or terminate ligand binding onto the receptor. E.g. Thyroid Hormone 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 63
  64. 64. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 64
  65. 65. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 65
  66. 66. CONCLUSION  The entire signal transduction system normally works astonishingly well, but serious problems can occur.  Cancer is unregulated cell growth and occurs when the machinery tightly regulating cell growth breaks down.  Mutations in growth factor receptors, G proteins, MAP kinases, and other molecules frequently contribute to cancer, and generally result in these molecules losing their normal switching function, staying in the activated form and therefore inappropriately stimulating these important enzyme cascades. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 66
  67. 67.  The complexity of the signaling system makes for challenging research, but once understood it holds the promise for better treatments for cancer and other diseases.  This is because each step in each pathway provides one or more targets for drugs.  Designing a drug that could quiet the excess signaling caused by defective MAP kinase, for example, might provide a promising cancer treatment. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 67
  68. 68.  The examples given thus far provide only an outline of how signal transduction cascades work and an overview of a few of the most important enzymes.  The actual process is much more complex, and there is much about the process that remains mysterious.  Perhaps the biggest mystery is how the cell makes sense of all of the input from different growth factors, hormones, extracellular substrates, and so on to produce an appropriate response. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 68
  69. 69.  The solution to this problem will result from a complete understanding and computer modeling of the biochemical and kinetic properties of the components of all these signaling cascades. _______________________.____________________________ 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 69
  70. 70. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 70
  71. 71.  REFRENCES 1. KUMAR, ABBAS AND COTRAN, ROBBINS BASIC PATHOLOGY OF DISEASES, NINTH EDITION 2. GUYTON AND HALL, TEXT BOOK OF MEDICAL PHYSIOLOGY, ELEVENTH EDITION. 3. KIM E BARRET, SUSAN M BARMAN, SCOT BIOTANO,GANONG’S MDEICAL PHYSIOLOGY, TWENTY THIRD EDITION. 4. INTERNET SOURCES. 1/19/2016SIGNAL TRANSDUCTION MECHANISMS 71

×